SCHEMBL693891

SCHEMBL693891

COc1ccc(CN(C(=O)O)c2ccc(C(=O)C3CCCc4nc(NC(C)=O)sc4C3=O)cn2)c(OC)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.37
LMNA P02545 3/20 0.37
GAA P10253 2/20 0.37
HPGD P15428 1/20 0.37
POLB P06746 4/20 0.36
ALDH1A1 P00352 4/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
TDP1 Q9NUW8 2/20 0.36
RECQL P46063 1/20 0.36
P4HTM Q9NXG6 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ADORA3 P0DMS8 1/20 0.34
ADORA2B P29275 1/20 0.34
PIK3CG P48736 1/20 0.34
TP53 P04637 3/20 0.34
PPARG P37231 1/20 0.34
NCOA2 Q15596 1/20 0.34
NPC1 O15118 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12598928 0.92 NOX1 (0.38) MAPTLMNAGAAHPGDPOLB
SCHEMBL1770304 0.91 MAPT (0.37) MAPTLMNAGAAHPGDPOLB
SCHEMBL12598920 0.84 TSHR (0.40) MAPTLMNAGAAHPGDALDH1A1
SCHEMBL12598910 0.80 ALDH1A1 (0.39) MAPTLMNAGAAHPGDPOLB
SCHEMBL12598911 0.78 ALDH1A1 (0.36) MAPTLMNAGAAHPGDPOLB
SCHEMBL12649327 0.77 GPR119 (0.35) MAPTLMNAGAAHPGDPOLB
SCHEMBL692071 0.76 TSHR (0.37) MAPTLMNAGAAPOLBALDH1A1
SCHEMBL12598914 0.76 TSHR (0.41) MAPTLMNAGAAHPGDPOLB
SCHEMBL12649472 0.75 LMNA (0.36) MAPTLMNAGAAHPGDPOLB
SCHEMBL1770594 0.74 PIK3CG (0.40) MAPTLMNAGAAHPGDPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421871-A1 THIA-TRIAZA-CYCLOPENTAZULENES AS PI3-KINASES INHIBITORS FOR THE TREATMENT OF CANCER Boehringer Ingelheim International GmbH (DE) 2012-02-29 EP disclosed
WO-2010122071-A1 THIA-TRIAZA-CYCLOPENTAZULENES AS PI3-KINASES INHIBITORS FOR THE TREATMENT OF CANCER BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-10-28 WO disclosed